Clinical Trial Update: A Clinical Study on the Effect of Discontinuing Alendronate in Postmenopausal Women With Osteoporosis After a Treatment Period Without Fractures [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating whether discontinuing alendronate after a fracture-free treatment period is safe and effective in postmenopausal women with os…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoporosis

Drugs mentioned

• alendronate (alendronate)

Snippet

Sponsor: Odense University Hospital | Conditions: Osteoporosis in Post-menopausal Women | Phase 4 | Status: RECRUITING